You are here

Clinical Trials: Heart Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, July 21, 2017 - 12:00
Condition:   Heart Failure
Interventions:   Biological: Intramyocardial injection of stem cell;   Biological: Placebo
Sponsor:   SCARM Institute, Tabriz, Iran
Not yet recruiting - verified July 2017
Posted: Tuesday, July 4, 2017 - 12:00
Conditions:   Coronary Heart Disease;   Angina Pectoris;   Myocardial Infarction
Interventions:   Device: COMBO;   Device: ORSIRO
Sponsors:   Aarhus University Hospital Skejby;   Biotronik SE & Co. KG;   OrbusNeich
Recruiting - verified July 2017
Posted: Tuesday, June 6, 2017 - 12:00
Condition:   Heart Failure
Interventions:   Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#);   Drug: conventional treatment
Sponsor:   Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified May 2017
Posted: Tuesday, May 2, 2017 - 12:00
Conditions:   Myocardial Infarction;   Heart Failure
Interventions:   Biological: Intracoronary injection of stem cell;   Biological: Placebo
Sponsor:   SCARM Institute, Tabriz, Iran
Not yet recruiting - verified July 2017
Posted: Friday, April 14, 2017 - 12:00
Condition:   Dilated Cardiomyopathy
Intervention:   Biological: CDC infusion
Sponsors:   Okayama University;   Translational Research Informatics Center, Kobe, Hyogo, Japan
Recruiting - verified April 2017
Posted: Tuesday, April 11, 2017 - 12:00
Condition:   Stem Cell Transplant Complications
Intervention:   Biological: autologous bone marrow mesenchymal stem cells
Sponsor:   Assiut University
Not yet recruiting - verified June 2017
Posted: Wednesday, March 8, 2017 - 12:00
Conditions:   Hypoplastic Left Heart Syndrome;   Atrioventricular Canal
Intervention:   Biological: MPC; rexlemestrocel-L
Sponsor:   Boston Children’s Hospital
Not yet recruiting - verified March 2017
Posted: Sunday, February 12, 2017 - 12:00
Condition:   Quality of Life
Interventions:   Drug: Caduet 10Mg-20Mg Tablet;   Drug: NorvasC® 10 mg Tablets
Sponsor:   Kosin University Gospel Hospital
Not yet recruiting - verified February 2017
Posted: Tuesday, February 7, 2017 - 12:00
Conditions:   Myocardial Infarction;   Stem Cell Transplantation;   Angioplasty, Transluminal, Percutaneous Coronary
Interventions:   Drug: Atorvastatin;   Drug: Intensive Atorvastatin;   Drug: Low dose BMMSC;   Drug: Middle dose BMMSC;   Drug: High dose BMMSC;   Drug: Transplantation
Sponsors:   Yuejin Yang;   Peking Union Medical College Hospital;   The First Hospital of Hebei Medical University;   Zunyi Medical College
Not yet recruiting - verified February 2017
Posted: Wednesday, November 23, 2016 - 12:00
Conditions:   Endothelial Progenitor Cells;   Coronary Artery Disease;   Vascular Injury;   Coronary Angiography
Intervention:   Biological: Administration of radio labelled endothelial outgrowth cells
Sponsors:   University of Edinburgh;   British Heart Foundation
Recruiting - verified October 2016

Pages